
Scottish Breast Studies Group
The Scottish Breast Studies Group is a multidisciplinary research collaborative for Scotland.
News
Next webinar
HER2-RADiCAL: less treatment after a complete response?
Friday 6 November 2026, 13:10 to 13:40, Microsoft Teams
Professor Iain MacPherson (University of Glasgow) describes HER2-RADiCAL, a UK trial testing whether people with HER2-positive early breast cancer who respond completely to treatment before surgery can safely receive less treatment afterwards. Chaired by Dr Caroline Michie (Edinburgh Cancer Centre).
Watch again
CESAR trial update: contrast-enhanced mammography versus MRI
Recorded 5 October 2026
Dr Sarah Savaridas reports progress on CESAR, which compares contrast-enhanced mammography with MRI for assessing response to neoadjuvant chemotherapy, and discusses with Professor Gerald Lip where the technique adds most value in Scotland.
Survey
PRIORITY-BC: help shape the next breast cancer trials
Closes Monday 9 November 2026
The UK Breast Cancer Clinical Studies Group and partners ask clinicians who treat early breast cancer which questions the next three or four NIHR-funded UK trials should answer. The survey takes a few minutes.
Conference
EBCSS 2027: Edinburgh Breast Cancer Special Symposium
Thursday 25 and Friday 26 February 2027, Edinburgh International Conference Centre
The Edinburgh Breast Cancer Special Symposium takes place in Edinburgh in February 2027, with more than 30 keynote lectures across 12 themes from speakers including Lisa Carey, Judy Boughey, Giuseppe Curigliano, Fatima Cardoso and David Cameron. A public lecture and panel discussion on breast cancer takes place on Wednesday 24 February at 16:30.
Mailing List
To receive updates on collaborative research opportunities, webinars, and meetings, healthcare professionals may join our mailing list.
Network mailing list information
Guest perspective
From the blog
Playing with other people's data
Two global cancer data collaborations use opposite approaches but point to the same priority: Scotland gains influence when it contributes good data through coordinated research.
Read the article